Senseonics Holdings, Inc. (SENS) News & Overview - Discounting Cash Flows
SENS
Senseonics Holdings, Inc.
SENS (AMEX)

SENS's Business Model

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Sector & Industry Healthcare / Medical - Devices
Website https://www.senseonics.com
CEO (Chief Executive Officer) Timothy T. Goodnow
Number of Employees
IPO date December 22, 2015

SENS Latest News

Contact
CountryUS
Address20451 Seneca Meadows Parkway
CityGermantown
StateMD
Phone301 515 7260
Zip Code20876-7005
Other Identifiers
CIK0001616543
ISINUS81727U1051
CUSIP81727U105
Open0.4951
Previous Close0.49
Volume2.51 Mil.
Average Volume5.52 Mil.
Day’s Range0.49 – 0.504
52 Week Range0.25-1.4
MA (50)0.57148
MA (200)0.57073
Market Cap379 Mil.
Shares Out.754.3 Mil.
Earnings DateAug 06, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for SENS

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us